We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+21.9%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$57.6B
AUM Growth
+$7.69B
(+15%)
Cap. Flow
+$3.7B
Cap. Flow
% of AUM
6.42%
Top 10 Holdings %
Top 10 Hldgs %
40.22%
Holding
1,054
New
202
Increased
277
Reduced
473
Closed
81
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America Series L
BAC.PRL
|
+$3.4B |
| 2 |
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
|
+$885M |
| 3 |
Tesla
TSLA
|
+$252M |
| 4 |
Amazon
AMZN
|
+$156M |
| 5 |
CLVT.PRA
Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares
CLVT.PRA
|
+$144M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$379M |
| 2 |
Sherwin-Williams
SHW
|
+$161M |
| 3 |
NVIDIA
NVDA
|
+$154M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$116M |
| 5 |
Boeing
BA
|
+$80M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.6% |
| 2 | Consumer Discretionary | 15.59% |
| 3 | Communication Services | 15.36% |
| 4 | Healthcare | 13.38% |
| 5 | Financials | 10.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Alkermes
ALKS
$8.29B
| $9.33M | 0.02% |
+330,994
| New | +$9.02M |
|
327
LSB Industries
LXU
$726M
| $9.28M | 0.02% |
898,364
-9,293
| -1% | -$113K |
|
328
Ecovyst
ECVT
$1.1B
| $9.14M | 0.02% |
+827,452
| New | +$8.56M |
|
329
Atlanta Braves Holdings Series B
BATRK
$3.21B
| $8.8M | 0.02% |
261,153
-2,350
| -0.9% | -$79.1K |
|
|
KE
330
Kimball Electronics
KE
$605M
| $8.78M | 0.02% |
364,361
+730
| +0.2% | +$17.8K |
|
331
Columbus McKinnon
CMCO
$557M
| $8.73M | 0.02% |
234,867
-1,724
| -0.7% | -$62.5K |
|
332
AbbVie
ABBV
$438B
| $8.63M | 0.02% |
54,143
-1,075
| -2% | -$164K |
|
333
Delek US
DK
$3.72B
| $8.49M | 0.01% |
369,925
+81,813
| +28% | +$2.05M |
|
334
Alta Equipment Group
ALTG
$237M
| $8.42M | 0.01% |
531,132
-7,478
| -1% | -$126K |
|
335
Broadcom
AVGO
$2.01T
| $8.38M | 0.01% |
130,580
+4,100
| +3% | +$247K |
|
|
MRC
336
DELISTED
MRC Global
MRC
| $8.32M | 0.01% |
856,122
-11,523
| -1% | -$131K |
|
337
John Wiley & Sons Class A
WLY
$2.62B
| $8.28M | 0.01% |
213,596
+63,441
| +42% | +$2.7M |
|
|
XIFR
338
XPLR Infrastructure LP
XIFR
$1.07B
| $8.26M | 0.01% |
136,019
-4,343
| -3% | -$299K |
|
|
ARNC
339
DELISTED
Arconic Corporation
ARNC
| $8.15M | 0.01% |
310,625
-2,592
| -0.8% | -$63.7K |
|
340
Griffon
GFF
$4.75B
| $8.02M | 0.01% |
250,621
-2,992
| -1% | -$110K |
|
341
Post Holdings
POST
$3.45B
| $7.98M | 0.01% |
88,771
-1,616
| -2% | -$147K |
|
342
ICICI Bank
IBN
$108B
| $7.91M | 0.01% |
366,737
-43,358
| -11% | -$905K |
|
|
GTLS
343
DELISTED
Chart Industries
GTLS
| $7.66M | 0.01% |
61,072
-4,505
| -7% | -$580K |
|
344
Neogen
NEOG
$2.49B
| $7.58M | 0.01% |
409,074
-30,116
| -7% | -$566K |
|
345
Procter & Gamble
PG
$340B
| $7.55M | 0.01% |
50,752
+573
| +1% | +$81.9K |
|
346
Cannae Holdings
CNNE
$644M
| $7.48M | 0.01% |
370,653
-3,971
| -1% | -$87.9K |
|
|
MDRX
347
DELISTED
Veradigm Inc. Common Stock
MDRX
| $7.42M | 0.01% |
568,531
-1,218,345
| -68% | -$19.7M |
|
348
Janus International
JBI
$732M
| $7.31M | 0.01% |
741,731
-5,783
| -0.8% | -$60.2K |
|
349
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.79B
| $7.27M | 0.01% |
+292,500
| New | +$7.21M |
|
350
State Street Blackstone Senior Loan ETF
SRLN
$5.35B
| $7.21M | 0.01% |
174,000
+165,985
| +2,071% | +$6.91M |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q1 2023 Portfolio in Review
As of Q1 2023, Loomis, Sayles & Company held 1,054 positions worth $57.6B, up 15% from $49.9B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Loomis, Sayles & Company deployed $3.7B of net new capital in Q1 2023, opening 202 new positions and adding to 277 existing holdings. Its largest new stake was Bank of America Series L: 2,835,020 shares worth $81.1M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was Novartis, an estimated $379M trimmed.
- Loomis, Sayles & Company's largest Q1 2023 buy was Bank of America Series L: 2,835,020 shares worth $81.1M.
- Loomis, Sayles & Company added most to Tesla in Q1 2023, an estimated $252M increase.
- Loomis, Sayles & Company's biggest Q1 2023 reduction was Novartis, cutting an estimated $379M.
- Loomis, Sayles & Company fully exited Globus Medical in Q1 2023, selling an estimated $38M.
- Loomis, Sayles & Company's ten largest holdings make up 40% of its $57.6B portfolio in Q1 2023.
- Loomis, Sayles & Company opened 202 new positions and closed 81 in Q1 2023.
- Loomis, Sayles & Company's portfolio value rose 15% quarter-over-quarter to $57.6B.
Based on Loomis, Sayles & Company's 13F filing for Q1 2023, filed 11 May 2023.